The one piece of this I think could immediately impact consumers and the industry has been having discussions with the administration about this, is Offering some kind of portal, some kind of online portal, a direct to consumer portal where companies would agree to sell to consumers directly for those who are underinsured or uninsured drugs at MFN type pricing. for heavily rebated drugs. And in those instances probably the ex U S prices are pretty close to the U S based prices once you factor in all the rebates … (04:03–04:16)
CLAIM
Asserts the proposal of a direct-to-consumer portal for drug sales at MFN pricing.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
